EGEN, Inc., is a clinical stage biopharmaceutical company focused on developing nucleic acid-based therapeutics for cancer and other difficult to treat diseases using proprietary nanoparticle delivery systems. They came to Axxiem looking for a simple, attractive, modern site that would showcase and clearly explain their proprietary technology.
Axxiem developed a new site for EGEN that showcases their TheraPlas and TheraSilence technologies and features up-to-date information about the status of their clinical trials and R&D pipeline. The uncluttered, visually engaging site is easy to navigate and allows visitors to quickly learn all the key information about the company and its offering. The homepage features an eye-catching artistic representation of EGEN's biopharmaceutical delivery technology.